Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
34.96B | 30.26B | 43.15B | 35.87B | 39.33B | 49.42B | Gross Profit |
5.40B | 3.99B | 8.25B | 4.63B | 5.20B | 3.40B | EBIT |
1.43B | 234.00M | 4.31B | 1.23B | 1.79B | 320.00M | EBITDA |
3.09B | 2.06B | 6.35B | 2.56B | 4.09B | 1.50B | Net Income Common Stockholders |
2.00B | 560.00M | 4.37B | 1.18B | 2.77B | 662.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.03B | 6.35B | 11.72B | 7.63B | 9.94B | 4.35B | Total Assets |
59.73B | 58.84B | 59.56B | 55.49B | 61.50B | 66.02B | Total Debt |
6.10B | 5.41B | 4.92B | 9.10B | 15.72B | 22.43B | Net Debt |
-1.93B | -937.00M | -6.81B | 1.46B | 5.78B | 18.08B | Total Liabilities |
26.97B | 25.22B | 27.06B | 28.20B | 37.02B | 44.70B | Stockholders Equity |
32.76B | 33.61B | 32.50B | 27.29B | 24.47B | 21.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | -5.77B | 8.26B | 5.22B | 12.10B | -408.00M | Operating Cash Flow |
0.00 | -4.86B | 8.93B | 5.92B | 12.95B | 24.00M | Investing Cash Flow |
0.00 | -576.00M | 2.58B | -652.00M | -4.03B | -128.00M | Financing Cash Flow |
0.00 | -14.00M | -4.62B | -8.26B | -6.48B | -695.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥19.51B | 7.99 | 4.99% | 16.52% | 39.65% | ||
76 Outperform | ¥27.90B | 11.88 | 4.54% | 4.40% | 18.83% | ||
74 Outperform | ¥50.87B | 11.74 | 1.64% | 37.64% | 69.78% | ||
71 Outperform | $29.70B | 4.63 | 10.04% | 1.94% | 9.41% | 19.24% | |
66 Neutral | $4.44B | 12.08 | 5.34% | 5.82% | 4.17% | -11.81% | |
66 Neutral | ¥31.35B | 24.73 | 2.02% | 0.68% | -22.88% | ||
62 Neutral | ¥14.33B | 25.58 | 2.40% | -29.89% | -87.19% |